Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
FDA approval of the drug for weight loss is expected this year or early next year
You may increase three months later
Learn more Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist
Regular blood work is recommended to monitor bicarbonate levels
Alongside plan growth, MA enrollment has also surged, from 31% in 2014 to 54% in 2024.[v] This trendline is expected to continue
PMCID: PMC3664505
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 20.48
US$ 24.70
US$ 26.47
US$ 29.40
US$ 26.52
